Schedule 13G ownership disclosure

Regulus Therapeutics Inc.

Security class unavailable · CUSIP: 75915K101

Event date: 2017-04-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-17-000743
Form type
SC 13G
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
May 05, 2017
Reporting period
Apr 26, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub